Literature DB >> 22105772

The role of lateral lymph node dissection in the management of lower rectal cancer.

Ziting Wang1, Kep Yong Loh, Kok-Yang Tan, Emile Chung-Hou Woo.   

Abstract

INTRODUCTION: Lateral lymph node involvement is a problem encountered in patients with low rectal cancers. This has been documented in both anatomical and pathological studies. Currently, the vast majority of centers have concentrated on the use of chemoradiation to obtain better local control and manage these nodes indirectly. In Japan, extended nodal dissection for the control of pelvic nodal disease has seen further advancement. This paper discusses the key issues involved in the management of pelvic lateral nodes in low rectal cancers.
METHODS: A review of available literature and critical appraisal of the entity of lateral nodes in low rectal cancers, the treatment options, and oncological and functional results were performed.
RESULTS: There are good data showing that the entity of pelvic lateral nodes in low rectal cancers should not be ignored. Recent data have emerged showing that radiotherapy is associated with significant long-term functional side effects. Refinement of the technique, lateral node dissection, has led to good local control as well as good functional outcomes.
CONCLUSION: In this context, there needs to be a reevaluation of the role of chemoradiation as the sole treatment for lateral nodal disease in centers outside of Japan. Individualization of the treatment of rectal cancer may require all centers to be able to offer both modalities.

Entities:  

Mesh:

Year:  2011        PMID: 22105772     DOI: 10.1007/s00423-011-0864-x

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  59 in total

1.  Lateral lymph node dissection in rectal cancer patients: is there any indication?

Authors:  Benno Mann
Journal:  Int J Colorectal Dis       Date:  2003-11-22       Impact factor: 2.571

Review 2.  Is the lateral lymph node compartment relevant?

Authors:  Moritz Koch; Peter Kienle; Dalibor Antolovic; Markus W Büchler; Jürgen Weitz
Journal:  Recent Results Cancer Res       Date:  2005

3.  Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection.

Authors:  Tae Hyun Kim; Seung-Yong Jeong; Dong Hyun Choi; Dae Yong Kim; Kyung Hae Jung; Sung Ho Moon; Hee Jin Chang; Seok-Byung Lim; Hyo Seong Choi; Jae-Gahb Park
Journal:  Ann Surg Oncol       Date:  2007-12-05       Impact factor: 5.344

4.  Lateral lymph node dissection for lower rectal cancer.

Authors:  Manabu Shiozawa; Makoto Akaike; Roppei Yamada; Teni Godai; Naoto Yamamoto; Hiroshige Saito; Yukio Sugimasa; Shoji Takemiya; Yasushi Rino; Toshio Imada
Journal:  Hepatogastroenterology       Date:  2007-06

5.  Incidence and prognostic significance of lateral lymph node metastasis in patients with advanced low rectal cancer.

Authors:  M Ueno; M Oya; K Azekura; T Yamaguchi; T Muto
Journal:  Br J Surg       Date:  2005-06       Impact factor: 6.939

6.  Local recurrences following colorectal operations.

Authors:  J Regös; L Nagy; Z Nagy; K Morvay
Journal:  Acta Chir Hung       Date:  1990

7.  Outcomes of surgery alone for lower rectal cancer with and without pelvic sidewall dissection.

Authors:  Hirotoshi Kobayashi; Hidetaka Mochizuki; Tomoyuki Kato; Takeo Mori; Shingo Kameoka; Kazuo Shirouzu; Kenichi Sugihara
Journal:  Dis Colon Rectum       Date:  2009-04       Impact factor: 4.585

8.  Patterns of local recurrence in rectal cancer; a study of the Dutch TME trial.

Authors:  M Kusters; C A M Marijnen; C J H van de Velde; H J T Rutten; M J Lahaye; J H Kim; R G H Beets-Tan; G L Beets
Journal:  Eur J Surg Oncol       Date:  2010-01-21       Impact factor: 4.424

9.  Presentation and prognosis of local recurrence after total mesorectal excision.

Authors:  C de Chaisemartin; C Penna; D Goere; S Benoist; A Beauchet; C Julie; B Nordlinger
Journal:  Colorectal Dis       Date:  2008-04-28       Impact factor: 3.788

10.  Late gastrointestinal disorders after rectal cancer surgery with and without preoperative radiation therapy.

Authors:  H Birgisson; L Påhlman; U Gunnarsson; B Glimelius
Journal:  Br J Surg       Date:  2008-02       Impact factor: 6.939

View more
  5 in total

1.  The important risk factor for lateral pelvic lymph node metastasis of lower rectal cancer is node-positive status on magnetic resonance imaging: study of the Lymph Node Committee of Japanese Society for Cancer of the Colon and Rectum.

Authors:  Shimpei Ogawa; Jin-Ichi Hida; Hideyuki Ike; Tetsushi Kinugasa; Mitsuyoshi Ota; Eiji Shinto; Michio Itabashi; Takahiro Okamoto; Kenichi Sugihara
Journal:  Int J Colorectal Dis       Date:  2016-08-30       Impact factor: 2.571

2.  Prediction of lateral pelvic lymph node metastasis from lower rectal cancer using magnetic resonance imaging and risk factors for metastasis: Multicenter study of the Lymph Node Committee of the Japanese Society for Cancer of the Colon and Rectum.

Authors:  Shimpei Ogawa; Jin-Ichi Hida; Hideyuki Ike; Tetsushi Kinugasa; Mitsuyoshi Ota; Eiji Shinto; Michio Itabashi; Takahiro Okamoto; Masakazu Yamamoto; Kenichi Sugihara; Toshiaki Watanabe
Journal:  Int J Colorectal Dis       Date:  2017-07-31       Impact factor: 2.571

Review 3.  Total mesorectal excision with and without lateral lymph node dissection: a systematic review of the literature.

Authors:  Gregoire Longchamp; Jeremy Meyer; Niki Christou; Sotirios Popeskou; Elin Roos; Christian Toso; Nicolas C Buchs; Frédéric Ris
Journal:  Int J Colorectal Dis       Date:  2020-05-27       Impact factor: 2.571

4.  Comparison of guidelines for the management of rectal cancer.

Authors:  E Luzietti; G Pellino; S Nikolaou; S Qiu; S Mills; O Warren; P Tekkis; C Kontovounisios
Journal:  BJS Open       Date:  2018-07-27

Review 5.  Lateral lymph node dissection for low rectal cancer: Is it necessary?

Authors:  Niki Christou; Jeremy Meyer; Christian Toso; Frédéric Ris; Nicolas Christian Buchs
Journal:  World J Gastroenterol       Date:  2019-08-21       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.